Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

4-Traders Homepage  >  Equities  >  London Stock Exchange  >  Anglo American    AAL   GB00B1XZS820

Mes dernières consult.
Most popular
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets

AstraZeneca pain weighs on FTSE, Diageo makes merry after results

share with twitter share with LinkedIn share with facebook
share via e-mail
07/27/2017 | 06:09pm CEST
FILE PHOTO: FILE PHOTO: A sign is seen at an AstraZeneca site in Macclesfield

LONDON (Reuters) - A punishing fall in AstraZeneca's shares after the failure of a key lung cancer study for the pharma company offset the impact of earnings-led gains for drinks giant Diageo on Britain's top share index.

Britain's FTSE 100 <.FTSE> index fell 0.2 percent on Thursday, in line with the broader European market.

It was a rough day for AstraZeneca (>> AstraZeneca) which lost around $13 billion (10 billion pounds) of its market value as its shares plunged 15.7 percent, its worst day on record.

The healthcare firm's combination of two injectable immunotherapy drugs, durvalumab and tremelimumab, failed to help patients as hoped in a study which was seen as key to proving the value of the group's new drug pipeline.

Analysts at Jefferies estimated that the failure of the study, known as MYSTIC, removed around 10 to 15 percent of mid-term earnings and valuation from the stock.

"With the failure of MYSTIC ... now likely to be fully factored into expectations, the dividend may now look less safe and we expect some investors will start to question its long-term sustainability, despite prior reassurances from management," analysts at Jefferies said in a note.

Wednesday's decision by the U.S. Federal Reserve to keep interest rates on hold was also weighing on the internationally-exposed FTSE, with banking stocks coming under pressure.

"The general interpretation from the Fed meeting in Europe has been that it's sending the euro and the pound higher, which is not good for our exporters," said Jasper Lawler, senior market analyst at London Capital Group.

"That environment probably exacerbated the fall we are seeing in Astra and some of the other shares as well."

It was better news for mid cap pharma stock Indivior (>> Indivior), whose shares surged 17.6 percent to the top of the European index after it reported first-quarter earnings, with Jefferies analysts highlighting a boost to the firm's operating leverage from a stronger U.S. market. [nL3N1KI30Z]

An earnings update also boosted shares in distilled drinks company Diageo (>> Diageo), which jumped 5.7 percent to an all-time high after raising its profitability target and announcing a share buyback programme.

Likewise pest control company Rentokil Initial (>> Rentokil Initial) gained 5.7 percent after reporting half-year results.

News that miner Anglo American (>> Anglo American) would resume dividend payments six months early helped its shares add around 3 percent.

The miner was forced to suspend its dividend during the commodity rout in 2015, but was helped by a rise in commodities prices last year as well as by cost-cutting measures.

Among mid-caps Acacia Mining (>> Acacia Mining PLC) jumped 15 percent, its best day in 13 months after a seven-day losing streak. Its parent company Barrick Gold (>> Barrick Gold Corp), the world's largest gold miner by production, said it would start talks with the Tanzanian government next week about an export ban which has helped wipe two-thirds of the stock's market value since it was announced in March.

(Reporting by Kit Rees; Editing by Keith Weir and Pritha Sarkar)

By Kit Rees and Helen Reid

Stocks mentioned in the article
ChangeLast1st jan.
ACACIA MINING -4.85% 111.75 Delayed Quote.-43.70%
ANGLO AMERICAN -1.37% 1599.8 Delayed Quote.3.25%
ASTRAZENECA -0.36% 5589 Delayed Quote.9.14%
BARRICK GOLD CORP -0.86% 16.23 Delayed Quote.-9.96%
DIAGEO 0.96% 2883.5 Delayed Quote.5.82%
FTSE 100 INDEX 0.28% 7234.11 End-of-day quote.-5.90%
INDIVIOR -3.29% 335.4 Delayed Quote.-17.83%
RENTOKIL INITIAL -1.88% 339.4 Delayed Quote.6.73%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ANGLO AMERICAN
07/19De Beers Buys Peregrine Diamonds for C$107 Million
07/19ANGLO AMERICAN : De Beers Group announcement
07/19ANGLO AMERICAN : De Beers agreement to acquire Peregrine Diamonds
07/19ANGLO AMERICAN : reports 6 percent rise in second quarter output
07/19Anglo American 2Q Total Production Rises 6%
07/19ANGLO AMERICAN : Q2 Production Report
07/18ANGLO AMERICAN : Crossing thresholds
07/17ANGLO AMERICAN : Platinum commits to venture capital
07/17ANGLO AMERICAN : Platinum commits to venture capital funds focused on increasing..
07/12Glencore shares under cloud after U.S demands Congo documents in probe
More news
News from SeekingAlpha
07/19Anglo American reports 6% production rise, raises platinum guidance 
07/12South African monthly gold production falls most since February 2017 
07/03A Review Of The North American EV Metal Miners 
06/27REUTERS : Anglo declares force majeure on contract after pipeline spills 
06/18Comparison Of The 2nd Tier Of Major Miners (11 To 20) 
Financials ($)
Sales 2018 27 103 M
EBIT 2018 5 863 M
Net income 2018 3 371 M
Debt 2018 2 656 M
Yield 2018 5,07%
P/E ratio 2018 8,53
P/E ratio 2019 9,52
EV / Sales 2018 1,19x
EV / Sales 2019 1,17x
Capitalization 29 648 M
Duration : Period :
Anglo American Technical Analysis Chart | AAL | GB00B1XZS820 | 4-Traders
Technical analysis trends ANGLO AMERICAN
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 24
Average target price 25,4 $
Spread / Average Target 21%
EPS Revisions
Mark Cutifani Chief Executive Officer & Executive Director
Stuart John Chambers Chairman
Stephen Thomas Pearce Finance Director & Non-Executive Director
Anthony Martin O'Neill Technical Director & Director
Philip Roy Hampton Senior Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
BHP BILLITON PLC5.97%124 856
RIO TINTO3.68%94 109